- Home
- SKYH vs ABEO Comparison
SKYH vs ABEO Comparison
Compare SKYH & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKYH
- ABEO
- Stock Information
- Founded
- SKYH 2017
- ABEO 1974
- Country
- SKYH United States
- ABEO United States
- Employees
- SKYH N/A
- ABEO N/A
- Industry
- SKYH Military/Government/Technical
- ABEO Biotechnology: Pharmaceutical Preparations
- Sector
- SKYH Industrials
- ABEO Health Care
- Exchange
- SKYH Nasdaq
- ABEO Nasdaq
- Market Cap
- SKYH 325.2M
- ABEO 332.0M
- IPO Year
- SKYH N/A
- ABEO 1980
- Fundamental
- Price
- SKYH $10.52
- ABEO $6.83
- Analyst Decision
- SKYH Strong Buy
- ABEO Strong Buy
- Analyst Count
- SKYH 3
- ABEO 6
- Target Price
- SKYH $14.83
- ABEO $18.17
- AVG Volume (30 Days)
- SKYH 104.9K
- ABEO 702.3K
- Earning Date
- SKYH 08-12-2025
- ABEO 08-14-2025
- Dividend Yield
- SKYH N/A
- ABEO N/A
- EPS Growth
- SKYH N/A
- ABEO N/A
- EPS
- SKYH N/A
- ABEO 0.99
- Revenue
- SKYH $20,919,000.00
- ABEO $400,000.00
- Revenue This Year
- SKYH $124.39
- ABEO N/A
- Revenue Next Year
- SKYH $83.05
- ABEO $339.63
- P/E Ratio
- SKYH N/A
- ABEO $6.91
- Revenue Growth
- SKYH 94.38
- ABEO N/A
- 52 Week Low
- SKYH $9.28
- ABEO $3.93
- 52 Week High
- SKYH $14.52
- ABEO $7.54
- Technical
- Relative Strength Index (RSI)
- SKYH 52.98
- ABEO 52.71
- Support Level
- SKYH $10.20
- ABEO $6.70
- Resistance Level
- SKYH $10.89
- ABEO $7.15
- Average True Range (ATR)
- SKYH 0.40
- ABEO 0.31
- MACD
- SKYH 0.02
- ABEO -0.02
- Stochastic Oscillator
- SKYH 46.43
- ABEO 46.62
About SKYH Sky Harbour Group Corporation
Sky Harbour Group Corp is an aviation infrastructure company building a nationwide network of Home-based solutions for business aircraft. The company develops, leases, and manages business aviation hangars across the United States based on its proprietary targeting and acquisition model, targeting airfields with hangar supply and demand imbalances in the markets. Its hangar campuses feature exclusive private hangars and a full suite of dedicated services specifically designed for home-based aircraft.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.